Evidence map›Paper›PMID 27226592›Full record

ArticleThe Journal of biological chemistry2016

The Endocytic Fate of the Transferrin Receptor Is Regulated by c-Abl Kinase.

Hong Cao, Barbara Schroeder, Jing Chen, Micah B Schott, Mark A McNiven

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hong CaoFrom the Department of Biochemistry and Molecular Biology, Center for Basic Research in Digestive Diseases, and.
Barbara SchroederDepartment of Experimental Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota 55905.
Jing ChenFrom the Department of Biochemistry and Molecular Biology, Center for Basic Research in Digestive Diseases, and.
Micah B SchottFrom the Department of Biochemistry and Molecular Biology, Center for Basic Research in Digestive Diseases, and.
Mark A McNivenFrom the Department of Biochemistry and Molecular Biology, Center for Basic Research in Digestive Diseases, and mmcniven@mayo.edu.
Mayo Clinic · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI Samar Ibrahim · 2009 to 2026
$22.2M
DIABETES AND METABOLISMT32DK007352 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL D. JENSEN · 1986 to 2026
$9.4M
CYTOSKELETAL REGULATION OF VESICLE TRANSPORT IN LIVERR01DK044650 · NIDDK · MAYO CLINIC ROCHESTER · PI MC NIVEN, MARK A. · 1997 to 2020
$3.3M
Cytoskeletal Regulation Of Vesicle Transport In LiverR37DK044650 · NIDDK · MAYO CLINIC ROCHESTER · PI MC NIVEN, MARK A. · 2007 to 2016
$3.2M
Cytoskeletal Regulation Of Vesicle Transport In LiverR56DK044650 · NIDDK · MAYO CLINIC ROCHESTER · PI MC NIVEN, MARK A. · 2022 to 2022
$398k
NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK044650NIDDK NIH HHS R37 DK044650NIDDK NIH HHS R56 DK044650NIDDK NIH HHS T32 DK007352
6 · The paper itself

Abstract

Clathrin-mediated endocytosis of transferrin (Tf) and its cognate receptor (TfR1) is a central pathway supporting the uptake of trophic iron. It has generally been assumed that this is a constitutive process. However, we have reported that the non-receptor tyrosine kinase, Src, is activated by Tf to facilitate the internalization of the Tf-TfR1 ligand-receptor complex. As an extension of these findings, we have tested whether subsequent trafficking steps might be regulated by additional kinase-dependent cascades, and we observed a significant endocytic block by inhibiting c-Abl kinase by a variety of methods. Importantly, Tf internalization was reduced significantly in all of these cell models and could be restored by re-expression of WT c-Abl. Surprisingly, this attenuated Tf-TfR1 endocytosis was due to a substantial drop in both the surface and total cellular receptor levels. Additional studies with the LDL receptor showed a similar effect. Surprisingly, immunofluorescence microscopy of imatinib-treated cells revealed a marked colocalization of internalized TfR1 with late endosomes/lysosomes, whereas attenuating the lysosome function with several inhibitors reduced this receptor loss. Importantly, inhibition of c-Abl resulted in a striking redistribution of the chaperone Hsc70 from a diffuse cytosolic localization to an association with the TfR1 at the late endosome-lysosome. Pharmacological inhibition of Hsc70 ATPase activity in cultured cells by the drug VER155008 prevents this chaperone-receptor interaction, resulting in an accumulation of the TfR1 in the early endosome. Thus, inhibition of c-Abl minimizes receptor recycling pathways and results in chaperone-dependent trafficking of the TfR1 to the lysosome for degradation. These findings implicate a novel role for c-Abl and Hsc70 as an unexpected regulator of Hsc70-mediated transport of trophic receptor cargo between the early and late endosomal compartments.

Indexed as

AnimalsAntigens, CDEndocytosisEndosomesHeLa CellsHSC70 Heat-Shock ProteinsHumansLysosomesProtein TransportProto-Oncogene Proteins c-ablRatsReceptors, TransferrinAntigens, CDCD71 antigenHSC70 Heat-Shock ProteinsHSPA8 protein, humanHspa8 protein, ratProto-Oncogene Proteins c-ablReceptors, TransferrinTfrc protein, ratABL tyrosine kinaseheat shock protein (HSP)lysosometraffickingtransferrin

Identifiers

PMID27226592
PMCPMC4974358
OpenAlexW2396492116

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.